Winslow et al. Neuron, vol. 14, pp. 973-981, 1995.* |
Barinaga, “Receptors Find Work as Guides” Science 269:1668-1670 (Sep. 22, 1995). |
Bartley et al., “B61 is a ligand for the ECK receptor protein-tyrosine kinase” Nature 368:558-560 (Apr. 7, 1994). |
Beckmann et al., “Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors” EMBO Journal 13(16):3757-3762 (1994). |
Berkemeier et al., “Neurotrophin-5: A Novel Neurotrophic Factor That Activates trk and trkB” Neuron 7:857-866 (Nov. 1991). |
Byrn et al., “Biological Properties of a CD4 Immunoadhesin” Nature 344:667-670 (Apr. 12, 1990). |
Camarata et al., “Sustained Release of Nerve Growth Factor from Biodegradable Polymer Microspheres” Neurosurgery 30(3):313-319 (1992). |
Canal, “Degenerative Disorders” Guidelines for Drug Trials in Memory Disorders 39:19-24 (1993). |
Capon et al., “Designing CD4 Immunoadhesins for AIDS Therapy” Nature 337:525-531 (1989). |
Cerretti et al., “The Gene Encoding LERK-7 (EPLG-7, Epl7), a Ligand for the Eph-related Tyrosine Kinases, Maps to Human Chromosome 5 at Band q21 and to Mouse Chromosome 17” Genomics 35:376-379 (1996). |
Cheng et al., “Identification and Cloning of ELF-1, a Developmentally Expressed Ligand for the Mek4 and Sek Receptor Tyrosine Kinases” Cell 79:157-168 (Oct. 7, 1994). |
Davis et al., “Ligands for EPH-Related Receptor Tyrosine Kinases That Require Membrane Attachment or Clustering for Activity” Science 266:816-819 (Nov. 4, 1994). |
de Leon et al., “In Vivo Structural Studies of the Hippocampus in Normal Aging and in Incipient Alzheimer's Disease” Annals of the New York Academy of Sciences 777:1-13 (1996). |
Drescher et al., “In Vitro Guidance of Retinal Ganglion Cell Axons by RAGS, a 25 kDa Tectal Protein Related to Ligands for Eph Receptor Tyrosine Kinases” Cell 82:359-370 (1995). |
Fox et al., “Atrophy of the Hippocampal Formation in Early Familial Alzheimer's Disease: A Longitudinal MRI Study of at-Risk Members of a Family With an Amyloid Precursor Protein 717 Val-Gly Mutation” Annals of the New York Academy of Sciences 777:226-232 (1996). |
Gilardi-Hebenstreit et al., “An Eph-related receptor protein tyrosine kinase gene segmentally expressed in the developing mouse hindbrain” Oncogene 7:2499-2506 (1992). |
Hefti et al., “Chronic Administration of Nerve Growth Factor and Other Neurotrophic Factors to the Brain” Neurobiology of Aging 9:689-690 (1988). |
Hefti, F., “Nerve Growth Factor Promotes Survival of Septal Cholinergic Neurons After Fimbrial Transections” J. of Neuroscience 6(8):2155-2162 (Aug. 1986). |
Hefti, F., “Neurotrophic Factor Therapy for Nervous System Degenerative Diseases” Journal of Neurobiology 25(11):1418-1435 (1994). |
Heumann, R., “Regulation of the Synthesis of Nerve Growth Factor” J. Exp. Biol. 132:133-150 (1987). |
Kaisho et al., “Cloning and expression of a cDNA encoding a novel human neurotrophic factor” FEBS Letters 266(1,2):187-191 (Jun. 1990). |
Lai et al., “An Extended Family of Protein-Tyrosine Kinase Genes Differentially Expressed in the Vertebrate Nervous System” Neuron 6:691-704 (May 1991). |
Leibrock et al., “Molecular Cloning and Expression of Brain-derived Neurotrophic Factor” Nature 341:149-152 (Sep. 14, 1989). |
Maisonpierre et al., “Ehk-1 and Ehk-2: two novel members of the Eph receptor-like tyrosine kinase family with distinctive structures and neuronal expression” Oncogene 8:3277-3288 (1993). |
Maisonpierre et al., “Neurotrophin-3: A Neurotrophic Factor Related to NGF and BDNF” Science 247:1446-1451 (Mar. 23, 1990). |
Mufson et al., “Intrastriatal and Intraventricular Infusion of Brain-Derived Neurotrophic Factor in the Cynomologous Monkey: Distribution, Retrograde Transport and Co-Localization with Substantia Nigra Dopamine-Containing Neurons” Neuroscience 71(1):179-191 (1996). |
Olson et al., “Intraputaminal Infusion of Nerve Growth Factor to Support Adrenal Medullary Autografts in Parkinson's Disease” Arch. Neurol. 48:373-381 (Apr. 1991). |
Olson, L., “NGF and the Treatment of Alzheimer's Disease” Experimental Neurology 124:5-15 (1993). |
Ringold et al., “Co-expression and Amplification of Dihydrofolate Reductase cDNA and the Escherichia coli XGPRT Gene in Chinese Hamster Ovary Cells” Journal of Molecular & Applied Genetics 1(3):165-175 (1981). |
Rosenthal et al., “Primary Structure and Biological Activity of a Novel Human Neurotrophic Factor” Neuron 4:767-773 (May 1990). |
Talmadge, J., “The Pharmaceutics and Delivery of Therapeutic Polypeptides and Proteins” Advanced Drug Delivery Reviews 10:247-299 (1993). |
Thoenen et al., “Physiology of Nerve Growth Factor” Physiological Reviews 60(4):1284-1335 (Oct. 1980). |
Tomlinson, “Ageing and the Dementias” Greenfield's Neuropathology, J. Hume Adams, Leo W. Duchen, Fifth edition, New York:Oxford University Press, Chapter 20, pp. 1284-1410 (1992). |
Tuzi et al., “eph, the largest known family of putative growth factor receptors” Br. J. Cancer 69:417-421 (1994). |
Winslow et al., “Cloning of AL-1, a Ligand for an Eph-Related Tyrosine Kinase Receptor Involved in Axon Bundle Formation” Neuron 14:973-981 (May 1995). |
Zhou et al., “Isolation and Characterization of Bsk, a Growth Factor Receptor-Like Tyrosine Kinase Associated With the Limbic System” J. of Neur. Res. 37:129-143 (1994). |